IRIS Accounts Production v24.3.2.46 07298219 director 1.7.23 30.6.24 30.6.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072982192023-06-30072982192024-06-30072982192023-07-012024-06-30072982192022-06-30072982192022-07-012023-06-30072982192023-06-3007298219ns15:EnglandWales2023-07-012024-06-3007298219ns14:PoundSterling2023-07-012024-06-3007298219ns10:Director12023-07-012024-06-3007298219ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3007298219ns10:SmallEntities2023-07-012024-06-3007298219ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3007298219ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3007298219ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3007298219ns10:FullAccounts2023-07-012024-06-3007298219ns10:RegisteredOffice2023-07-012024-06-3007298219ns5:CurrentFinancialInstruments2024-06-3007298219ns5:CurrentFinancialInstruments2023-06-3007298219ns5:ShareCapital2024-06-3007298219ns5:ShareCapital2023-06-3007298219ns5:RetainedEarningsAccumulatedLosses2024-06-3007298219ns5:RetainedEarningsAccumulatedLosses2023-06-3007298219ns5:PlantMachinery2023-07-012024-06-3007298219ns5:ComputerEquipment2023-07-012024-06-3007298219ns5:PlantMachinery2023-06-3007298219ns5:ComputerEquipment2023-06-3007298219ns5:PlantMachinery2024-06-3007298219ns5:ComputerEquipment2024-06-3007298219ns5:PlantMachinery2023-06-3007298219ns5:ComputerEquipment2023-06-3007298219ns5:AdditionsToInvestments2024-06-3007298219ns5:CostValuation2024-06-3007298219ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3007298219ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3007298219ns5:AcceleratedTaxDepreciationDeferredTax2024-06-3007298219ns5:AcceleratedTaxDepreciationDeferredTax2023-06-3007298219ns5:DeferredTaxation2023-06-3007298219ns5:DeferredTaxation2024-06-30072982191ns10:Director12023-06-30072982191ns10:Director12022-06-30072982191ns10:Director12023-07-012024-06-30072982191ns10:Director12022-07-012023-06-30072982191ns10:Director12024-06-30072982191ns10:Director12023-06-30
REGISTERED NUMBER: 07298219 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

FOR

BROBY DNA LTD

BROBY DNA LTD (REGISTERED NUMBER: 07298219)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BROBY DNA LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2024







DIRECTOR: M X Broby





REGISTERED OFFICE: Garden Flat
63 Redcliffe Gardens
London
SW10 9JJ





REGISTERED NUMBER: 07298219 (England and Wales)





ACCOUNTANTS: Numis Limited
1st Floor Pentagon House
Wealden Ind Estate
Farningham Road
Crowborough
East Sussex
TN6 2JR

BROBY DNA LTD (REGISTERED NUMBER: 07298219)

BALANCE SHEET
30 JUNE 2024

30.6.24 30.6.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 5,865 3,733
Investments 5 5,000 -
10,865 3,733

CURRENT ASSETS
Debtors 6 119 35,577
Cash at bank 455,069 405,094
455,188 440,671
CREDITORS
Amounts falling due within one year 7 31,928 51,302
NET CURRENT ASSETS 423,260 389,369
TOTAL ASSETS LESS CURRENT
LIABILITIES

434,125

393,102

PROVISIONS FOR LIABILITIES 8 1,312 672
NET ASSETS 432,813 392,430

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 432,713 392,330
SHAREHOLDERS' FUNDS 432,813 392,430

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BROBY DNA LTD (REGISTERED NUMBER: 07298219)

BALANCE SHEET - continued
30 JUNE 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 25 March 2025 and were signed by:





M X Broby - Director


BROBY DNA LTD (REGISTERED NUMBER: 07298219)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1. STATUTORY INFORMATION

Broby DNA Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance and 20% on reducing balance
Computer equipment - 25% on reducing balance and 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

BROBY DNA LTD (REGISTERED NUMBER: 07298219)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 July 2023 4,317 9,774 14,091
Additions - 3,599 3,599
At 30 June 2024 4,317 13,373 17,690
DEPRECIATION
At 1 July 2023 3,468 6,890 10,358
Charge for year 170 1,297 1,467
At 30 June 2024 3,638 8,187 11,825
NET BOOK VALUE
At 30 June 2024 679 5,186 5,865
At 30 June 2023 849 2,884 3,733

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 5,000
At 30 June 2024 5,000
NET BOOK VALUE
At 30 June 2024 5,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.24 30.6.23
£    £   
Trade debtors - 19,864
Tax 119 -
Accrued income - 15,713
119 35,577

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.24 30.6.23
£    £   
Tax 24,349 36,178
VAT 5,151 11,810
Directors' current accounts 427 1,299
Accrued expenses 2,001 2,015
31,928 51,302

BROBY DNA LTD (REGISTERED NUMBER: 07298219)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024

8. PROVISIONS FOR LIABILITIES
30.6.24 30.6.23
£    £   
Deferred tax
Accelerated capital allowances 1,312 672

Deferred
tax
£   
Balance at 1 July 2023 672
Accelerated capital allowances 640
Losses carried forward
Balance at 30 June 2024 1,312

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 June 2024 and 30 June 2023:

30.6.24 30.6.23
£    £   
M X Broby
Balance outstanding at start of year (1,299 ) (1,018 )
Amounts advanced (1,040 ) (1,040 )
Amounts repaid 1,912 759
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (427 ) (1,299 )

10. RELATED PARTY DISCLOSURES

During the year, total dividends of £30,000 (2023 - £82,000) were paid to the director .

11. ULTIMATE CONTROLLING PARTY

The controlling party is M X Broby.